3-(4-chlorobenzyl)indolin-2-one | 131609-35-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 3-(4-chlorobenzyl)indolin-2-one
• 英文别名: 3-(4-Chlorobenzyl)-1,3-dihydroindol-2-one；3-[(4-chlorophenyl)methyl]-1,3-dihydroindol-2-one
• CAS: 131609-35-3
• 化学式: C₁₅H₁₂ClNO
• 分子量: 257.719
• InChiKey: MNMZQPVZOVEXHO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  3-(4-chlorobenzyl)indolin-2-one 在 NO-Feng-PDiPPPi 、 scandium tris(trifluoromethanesulfonate) 、 sodium carbonate 、 N-氟代双苯磺酰胺 作用下， 以 氯仿 为溶剂， 反应 72.5h， 以98%的产率得到3-(4-chlorobenzyl)-3-fluoroindolin-2-one
  参考文献：
  名称：

  Highly Enantioselective Fluorination of Unprotected 3-Substituted Oxindoles: One-Step Synthesis of BMS 204352 (MaxiPost)

  摘要：

  The catalytic enantioselective fluorination of N-H-free 3-substituted oxindoles was accomplished by a Sc(III)/N,N'-dioxide complex. Under mild reaction conditions, a series of 3-aryl- and 3-alkyl-3-fluoro-2-oxindoles were obtained in excellent yields (up to 98%) and enantioselectivities (up to 99% ee) by using N-fluorobisbenzenesulfonimide (NFSI) as the fluorination agent. MaxiPost was synthesized efficiently in 81% yield with 96% ee.

  DOI：

  10.1021/jo301705t
• 作为产物：
  描述：

  3-(4-chlorobenzylidene)indolin-2-one 在 甲醇 、 sodium tetrahydroborate 作用下， 以601 mg的产率得到3-(4-chlorobenzyl)indolin-2-one
  参考文献：
  名称：

  3-取代羟吲哚的光化学去消旋作用

  摘要：

  基于二苯甲酮的催化剂被用作 3-取代羟吲哚光化学去消旋化的唯一手性来源。该反应可能通过氢原子转移进行并产生具有高对映体过量的所需产物及其衍生物。

  DOI：

  10.1002/anie.202305274

文献信息

• Ruthenium-Catalyzed Alkylation of Oxindole with Alcohols
  作者：Thomas Jensen、Robert Madsen

  DOI：10.1021/jo900341w

  日期：2009.5.15

  An atom-economical and solvent-free catalytic procedure for the mono-3-alkylation of oxindole with alcohols is described. The reaction is mediated by the in situ generated catalyst from RuCl3·xH2O and PPh3 in the presence of sodium hydroxide. The reactions proceed in good to excellent yields with a wide range of aromatic, heteroaromatic, and aliphatic alcohols.

  描述了用于羟吲哚与醇的单-3-烷基化的原子经济且无溶剂的催化方法。该反应由RuCl 3 · x H 2 O和PPh 3在氢氧化钠存在下原位生成的催化剂介导。使用多种芳族，杂芳族和脂族醇，反应可以以良好的收率进行，收率很高。
• C-3 alkylation of oxindole with alcohols by Pt/CeO₂ catalyst in additive-free conditions
  作者：Chandan Chaudhari、S. M. A. Hakim Siddiki、Kenichi Kon、Atsuko Tomita、Yutaka Tai、Ken-ichi Shimizu

  DOI：10.1039/c3cy00911d

  日期：——

  In a series of transition metal-loaded CeO2 catalysts and Pt-loaded catalysts on various supports, Pt-loaded CeO2 shows the highest activity for the selective C-3 alkylation of oxindole with octanol. The catalyst is effective for alkylation of oxindole and N-substituted oxindole with a series of substituted benzyl, linear, hetero-aryl alcohols under additive-free conditions and is recyclable. Our results

  在一系列负载在各种载体上的过渡金属负载的CeO 2催化剂和Pt负载的催化剂中，Pt负载的CeO 2对羟吲哚与辛醇的选择性C-3烷基化反应显示出最高的活性。该催化剂对于在一系列无添加剂条件下用一系列取代的苄基，线性，杂芳基醇对羟吲哚和N-取代的羟吲哚进行烷基化反应是有效的，并且是可回收的。我们的结果证明了该反应的第一个无添加剂催化体系。机理研究表明，该系统是由借氢途径驱动的。结构与活性之间的关系研究表明，在该催化体系中，Pt金属簇上的表面Pt 0物种与碱性载体共存是必不可少的。
• Iron‐Catalyzed Cross‐Dehydrogenative Coupling of Oxindoles with Thiols/Selenols for Direct C( <i>sp</i> ^<i>3</i> )−S/Se Bond Formation
  作者：Lu‐Shan Huang、Dong‐Yang Han、Da‐Zhen Xu

  DOI：10.1002/adsc.201900400

  日期：2019.9.3

  The C−X (S/Se) bonds are common and ubiquitous in natural products and pharmaceuticals. Here, we report an iron‐catalyzed cross‐dehydrogenative coupling (CDC) reaction for the direct synthesis of C(sp3)−X (S/Se) bonds from oxindoles, phenylacetamides, pyrazolones, phenylacetonitriles and ethyl cyanoacetate with thiols and selenols. All the reactions were performed under simple and mild conditions,

  C-X（S / Se）键在天然产物和药物中是常见且普遍存在的。在这里，我们报告了铁催化的交叉脱氢偶联（CDC）反应，该反应可从羟吲哚，苯乙酰胺，吡唑啉酮，苯乙腈和氰基乙酸乙酯与硫醇和硒醇直接合成C（sp 3）-X（S / Se）键。所有反应均在简单温和的条件下进行，并且空气（分子氧）被用作理想的绿色氧化剂，因此有望在化学工业和生物活性分子的改性中得到广泛应用。
• Tetrabutylammonium Iodide–Promoted Thiolation of Oxindoles Using Sulfonyl Chlorides as Sulfenylation Reagents
  作者：Xia Zhao、Aoqi Wei、Xiaoyu Lu、Kui Lu

  DOI：10.3390/molecules22081208

  日期：——

  of oxindoles using sulfonyl chlorides as sulfenylation reagents. The above reaction was promoted by iodide anions, which was ascribed to the in situ conversion of sulfenyl chlorides into the more reactive sulfenyl iodides. Moreover, the thiolation of 3-aryloxindoles was facilitated by bases. The use of a transition-metal-free protocol, readily available reagents, and mild reaction conditions make this

  使用磺酰氯作为亚磺酰化试剂，通过三苯基膦介导的无过渡金属的羟吲哚硫醇化反应合成了 3-磺基羟吲哚。上述反应由碘化物阴离子促进，这归因于亚磺酰氯原位转化为更具反应性的亚磺酰碘。此外，碱促进了 3-芳基羟吲哚的硫醇化。使用无过渡金属的协议、现成的试剂和温和的反应条件使该协议比传统方法更适用于制备 3-硫磺基吲哚。
• Phosphodiesterase inhibitors
  申请人：LES LABORATOIRES BEECHAM S.A.

  公开号：EP0381374A1

  公开（公告）日：1990-08-08

  A compound of formula (I), or a pharmaceutically acceptable salt thereof: in which, R₁ is hydrogen, C₁₋₆ alkyl or CH₂OR₆; R₂ is hydrogen or C₁₋₆ alkyl; R₃ is hydrogen or C₁₋₆ alkyl; each of W and Z, which are different, represents -CR₄R₅- or -(CRxRy)n-, in which, R₄ is hydrogen, C₁₋₃ alkyl, C₁₋₃ alkylthio, C₁₋₃ alkoxy or C₁₋₆ alkyl phenyl; R₅ is C₁₋₃ alkyl, C₁₋₃ alkylthio, C₁₋₃ alkoxy, phenyl, substituted phenyl, C₃₋₆ cycloalkyl, phenylthio, C₁₋₆ alkyl phenyl, halo-substituted benzyl, or heteroaryl; or together R₄ and R₅ form a 3 to 6 membered carbocyclic ring, or a heterocyclic ring containing one or two ring oxygen, nitrogen or sulphur atoms, or R₄ and R₅ together form an oxo or methylene group; each of Rx and Ry is hydrogen or C₁₋₃ alkyl; n is zero or 1; R₆ is phenyl substituted aminocarbonyl, C₁₋₆ alkoxy carbonyl-C₁₋₆ alkyl, phenyl-C₁₋₆ alkyl, phenyl, C₃₋₆ cycloalkylcarbonyl, C₃₋₆ cycloalkylcarbonyl-C₁₋₆ alkyl, C₃₋₆ cycloalkyl C₁₋₆ alkyl; C₁₋₆ alkylthiocarbonyl; halo-substituted C₁₋₆ alkoxycarbonyl; C₁₋₆ alkoxy C₁₋₆ alkyleneoxycarbonyl; C₁₋₆ alkylthio C₁₋₆ alkyleneoxycarbonyl; C₁₋₆ alkoxythiocarbonyl; C₃₋₆ cycloalkyloxycarbonyl; cyano substituted C₁₋₆ alkoxycarbonyl; di-C₁₋₆ alkylphosphonate; C₁₋₆ alkenyloxycarbonyl; or R₆ is hydrogen when R₅ is phenyl, C₃₋₆ cycloalkyl, phenylthio, C₁₋₆ alkylphenyl or halo-substituted benzyl; R₆ is benzoyl or aminobenzoyl when R₄ and R₅ form a C₃₋₆ cycloalkyl ring; R₇ is hydrogen, C₁₋₆ alkyl or halogen; X is oxygen or sulphur; and A is sulphur, oxygen or -NH-, is useful for the treatment of heart disease.

  式（I）的化合物，或其药学上可接受的盐：其中，R₁为氢，C₁₋₆烷基或CH₂OR₆；R₂为氢或C₁₋₆烷基；R₃为氢或C₁₋₆烷基；W和Z中的每一个，它们不同，代表-CR₄R₅-或-(CRxRy)n-，其中，R₄为氢，C₁₋₃烷基，C₁₋₃烷基硫，C₁₋₃烷氧基或C₁₋₆烷基苯基；R₅为C₁₋₃烷基，C₁₋₃烷基硫，C₁₋₃烷氧基，苯基，取代苯基，C₃₋₆环烷基，苯硫基，C₁₋₆烷基苯基，卤代苄基或杂环烷基；或者R₄和R₅一起形成3到6成员的碳环，或者含有一个或两个环氧原子、氮原子或硫原子的杂环；或者R₄和R₅一起形成氧或亚甲基基团；Rx和Ry中的每一个为氢或C₁₋₃烷基；n为零或1；R₆为苯基取代氨基甲酰基，C₁₋₆烷氧基甲酰基-C₁₋₆烷基，苯基-C₁₋₆烷基，苯基，C₃₋₆环烷基甲酰基，C₃₋₆环烷基甲酰基-C₁₋₆烷基，C₃₋₆环烷基C₁₋₆烷基；C₁₋₆烷基硫代甲酰基；卤代C₁₋₆烷氧基甲酰基；C₁₋₆烷氧基-C₁₋₆烷基氧基甲酰基；C₁₋₆烷基硫基-C₁₋₆烷基氧基甲酰基；C₁₋₆烷氧基硫代甲酰基；C₃₋₆环烷氧基甲酰基；氰基取代C₁₋₆烷氧基甲酰基；二C₁₋₆烷基膦酸酯；C₁₋₆烯氧基甲酰基；或者当R₅为苯基，C₃₋₆环烷基，苯硫基，C₁₋₆烷基苯基或卤代苄基时，R₆为氢；当R₄和R₅形成C₃₋₆环烷基环时，R₆为苯甲酰基或氨基苯甲酰基；R₇为氢，C₁₋₆烷基或卤素；X为氧或硫；A为硫，氧或-NH-，用于治疗心脏病。